50 mg and 100 mg tablets
Registration number: LP-000692
Pharmacotherapeutic group: Selective beta1-blocker
Indications for use:
Arterial hypertension (as a monotherapy or in combination with other antihypertensive agents), including the hyperkinetic type, tachycardia;
Coronary artery disease; myocardial infarction (secondary prophylaxis — comprehensive therapy), prevention of angina attacks;
Cardiac arrhythmias (supraventricular tachycardia and ventricular premature beats);
Hyperthyroidism (comprehensive therapy);
Prevention of migraine attacks.
50 mg and 100 mg tablets. 10 tablets in blister packaging. 1, 2, 3, 5 or 10 blister packs with instructions for use in carton packaging.